Clinical Evaluation and Determinants of Response to HBI0101 (BCMA CART) Therapy in Relapsed/refractory Multiple Myeloma
BLOOD ADVANCES(2024)
Key words
BCMA CART,point-of-care,academia,prognostic model of survival
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined